AI in Pharma
Article
The Patent Problem: Who Really Owns What AI Discovers in Science?
AI is discovering drugs but cannot own a patent. Explore who holds IP rights in AI-assisted pharma discovery and what your team mu...
Other latest pieces about AI in Pharma you may like to read
The Patent Problem: Who Really Owns What AI Discovers in Science?
AI is discovering drugs but cannot own a patent. Explore who holds IP rights in AI-assisted pharma discovery and what your team must do.
by Vaibhavi M.
When AI Gets It Wrong: The Real Patient Safety Risk of AI Hallucinations in Healthcare
AI hallucinations in pharma are a real patient safety risk. Wrong doses, false data, missed signals here's what governance looks like.
by Vaibhavi M.
Is Pharma's AI Investment Actually Paying Off? Here's What the Numbers Say
Pharma AI ROI, pharmacovigilance and manufacturing deliver 1-3 year returns. Drug discovery takes 7-12 years. Real data, honest measurement framework.
by Vaibhavi M.
How AI Is Changing the Way Pharma Research Teams Work
AI is reshaping pharma research teams, faster drug discovery, smarter decisions, and real results from companies already leading the shift.
by Vaibhavi M.
How AI Is Changing Drug Safety Monitoring - And What the Future Looks Like
How AI transforms drug safety | signal detection, adverse event automation, real-world evidence integration, and pharmacovigilance team augmentation.
by Vaibhavi M.
